Mass Specs, Instrument Business Push Bruker Q4 Revenues Up 16 Percent

After launching several instrument platforms in 2009, Bruker will now focus its mass spec business on developing "applications-driven solutions," CEO Frank Laukien said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.